Kaifeng Mingren Pharmaceutical Debuts at CPHI Frankfurt 2025

In 2025, Kaifeng Mingren Pharmaceutical Co., Ltd. will showcase its core products, including Berberine Hydrochloride, Tegoprazan series, and Phloroglucinol, at the CPHI Worldwide in Frankfurt, Germany (Booth No. 12.1H93). The Berberine Hydrochloride features high purity and stability, the Tegroprazan series boasts advanced technology with outstanding efficacy, and Phloroglucinol is known for its superior quality and broad applications.

These three products are popular for their solid quality and excellent performance. During the exhibition, the company’s team will also engage with global clients, offering professional services tailored to their needs and receiving widespread recognition, demonstrating its product strength and service advantages in the pharmaceutical raw materials field.